UY39335A - Forma cristalina de clorhidrato de fentermina y proceso de obtención de la misma - Google Patents

Forma cristalina de clorhidrato de fentermina y proceso de obtención de la misma

Info

Publication number
UY39335A
UY39335A UY0001039335A UY39335A UY39335A UY 39335 A UY39335 A UY 39335A UY 0001039335 A UY0001039335 A UY 0001039335A UY 39335 A UY39335 A UY 39335A UY 39335 A UY39335 A UY 39335A
Authority
UY
Uruguay
Prior art keywords
crystalline form
obtaining
hydrochloride
fentermine
same
Prior art date
Application number
UY0001039335A
Other languages
English (en)
Inventor
Felipe DE OLIVEIRA FARIA Luiz
Yuri Geronimo Kobata Pedro
Original Assignee
Eurofarma Laboratorios S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurofarma Laboratorios S A filed Critical Eurofarma Laboratorios S A
Publication of UY39335A publication Critical patent/UY39335A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/86—Separation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a la forma cristalina de clorhidrato de fentermina monohidratada y a procesos de obtención de dicha forma cristalina. Fentermina o 2-metil-1-fenilpropan-2-amina se encuentra en forma de sal de clorhidrato, siendo un estimulante del sistema nervioso central, utilizado como un supresor del apetito y estimulante en medicamentos. La presente invención se encuentra en los campos de la química y la farmacia.
UY0001039335A 2020-07-27 2021-07-22 Forma cristalina de clorhidrato de fentermina y proceso de obtención de la misma UY39335A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2020/050290 WO2022020910A1 (pt) 2020-07-27 2020-07-27 Forma cristalina de cloridrato de fentermina e processo de obtenção da mesma

Publications (1)

Publication Number Publication Date
UY39335A true UY39335A (es) 2021-11-30

Family

ID=79283588

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039335A UY39335A (es) 2020-07-27 2021-07-22 Forma cristalina de clorhidrato de fentermina y proceso de obtención de la misma

Country Status (10)

Country Link
US (1) US20230265043A1 (es)
EP (1) EP4190320A4 (es)
AR (1) AR123045A1 (es)
BR (1) BR112023001519A2 (es)
CA (1) CA3187100A1 (es)
CO (1) CO2023000499A2 (es)
MX (1) MX2023001136A (es)
PE (1) PE20231051A1 (es)
UY (1) UY39335A (es)
WO (1) WO2022020910A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2408345A (en) 1942-04-13 1946-09-24 Wm S Merrell Co Composition of matter and method
US20080293695A1 (en) 2007-05-22 2008-11-27 David William Bristol Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
CA2617688C (en) * 2007-02-22 2015-08-18 Alpex Pharma S.A. Solid dosage formulations containing weight-loss drugs
WO2009098169A1 (en) * 2008-02-05 2009-08-13 Alpex Pharma Sa Orally disintegrating tablets with speckled appearance
WO2010059658A1 (en) * 2008-11-20 2010-05-27 Glaxosmithkline Llc Chemical compounds
IN2012DE00826A (es) * 2012-03-21 2015-08-21 Ranbaxy Lab Ltd
CN103316026B (zh) * 2012-03-23 2016-05-11 中国人民解放军军事医学科学院毒物药物研究所 含芬特明和托吡酯的联合产品及其制备方法

Also Published As

Publication number Publication date
AR123045A1 (es) 2022-10-26
PE20231051A1 (es) 2023-07-11
CA3187100A1 (en) 2022-02-03
EP4190320A4 (en) 2024-05-01
MX2023001136A (es) 2023-03-21
EP4190320A1 (en) 2023-06-07
US20230265043A1 (en) 2023-08-24
BR112023001519A2 (pt) 2023-02-14
CO2023000499A2 (es) 2023-03-17
WO2022020910A1 (pt) 2022-02-03

Similar Documents

Publication Publication Date Title
BR112016017996A2 (pt) 6-heteroariloxi- or 6-ariloxi-quinolina-2-carboxamidas e método de uso
AR100818A1 (es) N-(cianometil)-4-(2-(4-morfolinofenilamino)pirimidin-4-il)benzamida
GT201700245A (es) Sal de (s)-csa de s-ketamina, sal de (r)-csa de s-ketamina y procesos para la preparación de s-ketamina
BR112017010354A2 (pt) compostos de triazolopirimidina e usos dos mesmos
AR085219A1 (es) 6-cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del snc
BR112017027831A2 (pt) derivados de hidroxiácido, um processo para sua preparação e composições farmacêuticas contendo-os
AR111233A1 (es) Inhibidores de tyk2, usos y métodos para la producción de los mismos
BRPI0808764B8 (pt) compostos espiro-substituídos como inibidores de angiogênese seu processo de produção e composição farmacêutica
CR20160135A (es) Compuestos de carboxamida de furo y tienopiridina útiles como inhibidores de cinasas pim
EA201791350A1 (ru) Радиофармацевтические комплексы
BR112014019357A8 (pt) Derivados de tetra-hidro- quinazolinona como inibidores de tanc e parp
CO2018007008A2 (es) "procesos mejorados para la preparación de osimertinib (azd9291) o una sal del mismo y "azd9291 anilina" o una sal del mismo"
CO2017010806A2 (es) Método para manufacturar compuesto novedoso que contiene nitrógeno o sal del mismo e intermediario de manufacturación del compuesto novedoso que contiene nitrógeno o sal del mismo
CO2019001181A2 (es) Compuestos de heteroarilcarboxamida como inhibidores de ripk2
AR112473A1 (es) Proceso para preparar amida de levodopa purificada
BR112017013130A2 (pt) processo de fabricação de cenicriviroc e análogos relacionados
BR112016001978A2 (pt) derivados de ciclopentano 1,3-dissubstituído
BR112018003489A2 (pt) n-[2-(2-amino-6,6-dissubstituído-4,4a,5,6-tetra-hidropirano[3,4-d][1,3]tiazin-8a(8h)-il)-1,3-tiazol-4-il]amidas
BR112016001928A2 (pt) derivados de piperidina ureia
BR112017025135A2 (pt) processos para isolar um composto e para preparar um composto
UY39335A (es) Forma cristalina de clorhidrato de fentermina y proceso de obtención de la misma
CL2023000185A1 (es) Forma cristalina de clorhidrato de fentermina y proceso de obtención de la misma
BR112018004347A2 (pt) derivados de éter cíclico de pirazolo[1,5-a]pirimidina-3-carboxiamida
BR112015010512A2 (pt) derivados de carboxamida de 3-aminociclopentano
BR112021006498A2 (pt) métodos de inativação de vírus para fabricação contínua de anticorpos